The director of hospital affairs and clinical services at Ahvaz University of Medical Sciences highlighted the identification of over 40 'EB' (Epidermolysis Bullosa) patients in Khuzestan, emphasizing the necessity for collaboration among responsible institutions to secure the medication supplies for these patients amid the country's sanctions.
Identification of Over 40 'Butterfly' Patients in Khuzestan / Challenge of Accessing Vital Medications
More than 40 patients with Epidermolysis Bullosa have been identified in Khuzestan, prompting calls for collaboration among health authorities to ensure access to essential medications despite ongoing sanctions. This situation underscores the challenges faced by vulnerable patients in Iran's healthcare system.
👥 Key Players
📰 What Happened
Over 40 patients with Epidermolysis Bullosa have been identified in Khuzestan, highlighting the urgent need for collaboration among health authorities to secure necessary medications amid sanctions.
- Epidermolysis Bullosa is a rare genetic condition that causes severe skin fragility.
- Sanctions have created significant barriers to accessing essential medications in Iran.
💡 Why It Matters
📚 Background
Epidermolysis Bullosa is a rare but severe condition that requires specialized treatment, which is increasingly difficult to obtain in Iran due to sanctions.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%